Shepherd Financial Partners’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-5,068
Closed -$354K 163
2022
Q1
$354K Sell
5,068
-319
-6% -$23.3K 0.06% 132
2021
Q4
$419K Sell
5,387
-14,209
-73% -$1.25M 0.07% 123
2021
Q3
$1.87M Buy
19,596
+4,439
+29% +$469K 0.36% 55
2021
Q2
$1.88M Buy
15,157
+166
+1% +$19.8K 0.36% 59
2021
Q1
$1.98M Buy
14,991
+216
+1% +$29.6K 0.44% 46
2020
Q4
$1.96M Buy
14,775
+421
+3% +$50.9K 0.45% 47
2020
Q3
$1.46M Buy
14,354
+859
+6% +$74.2K 0.34% 62
2020
Q2
$1.17M Buy
+13,495
New +$1.08M 0.32% 58

Other funds holding EXAS

Shepherd Financial Partners's EXAS Position: Q2 2022 in Review

Shepherd Financial Partners sold out of Exact Sciences (EXAS) in Q2 2022, closing a stake of 5,068 shares — an estimated $354K sold.

Shepherd Financial Partners first reported a position in EXAS in Q2 2020 and held it in 8 quarters. The position peaked at $1.98M in Q1 2021. 501 funds tracked by Wall St. Rank hold EXAS as of Q2 2022.

  • Shepherd Financial Partners reported no remaining Exact Sciences position as of Q2 2022 after selling out during the quarter.
  • Shepherd Financial Partners sold 5,068 Exact Sciences shares in Q2 2022, an estimated $354K.
  • Shepherd Financial Partners first reported a position in Exact Sciences in Q2 2020 and held it in 8 quarters.
  • Shepherd Financial Partners's Exact Sciences position peaked at $1.98M in Q1 2021.
  • 501 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2022.

Based on Shepherd Financial Partners's 13F filing for Q2 2022, filed 15 Aug 2022.